Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 466

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

Practical Aspects of microRNA Target Prediction

Open access
M. Witkos, T., Koscianska, E., J. Krzyzosiak, W.·2011·Current Molecular Medicine

Abstract

microRNAs (miRNAs) are endogenous non-coding RNAs that control gene expression at the posttranscriptional level. These small regulatory molecules play a key role in the majority of biological processes and their expression is also tightly regulated. Both the deregulation of genes controlled by miRNAs and the altered miRNA expression have been linked to many disorders, including cancer, cardiovascular, metabolic and neurodegenerative diseases. Therefore, it is of particular interest to reliably predict potential miRNA targets which might be involved in these diseases. However, interactions between miRNAs and their targets are complex and very often there are numerous putative miRNA recognition sites in mRNAs. Many miRNA targets have been computationally predicted but only a limited number of these were experimentally validated. Although a variety of miRNA target prediction algorithms are available, results of their application are often inconsistent. Hence, finding a functional miRNA target is still a challenging task. In this review, currently available and frequently used computational tools for miRNA target prediction, i.e., PicTar, TargetScan, DIANA-microT, miRanda, rna22 and PITA are outlined and various practical aspects of miRNA target analysis are extensively discussed. Moreover, the performance of three algorithms (PicTar, TargetScan and DIANAmicroT) is both demonstrated and evaluated by performing an in-depth analysis of miRNA interactions with mRNAs derived from genes triggering hereditary neurological disorders known as trinucleotide repeat expansion diseases (TREDs), such as Huntingtons disease (HD), a number of spinocerebellar ataxias (SCAs), and myotonic dystrophy type 1 (DM1). Keywords: Bioinformatics, gene regulation, miRNA, miRNA-mRNA interaction, neurodegeneration, target prediction algorithm, target validation, trinucleotide repeat expansion disorders, gene expression, RNA-induced silencing complex, computational miRNA target analysis, orthologous sequences alignment, high throughput methods, proteome level, miRNA inhibitors

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/156652411794859250

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 137 references

Cited by

See all 466

Metadata

Authors
M. Witkos, T., Koscianska, E., & J. Krzyzosiak, W.
Venue
Current Molecular Medicine
Published
2011-03-01
Volume
11
Issue
2
Pages
93-109
ISSN
1566-5240 (ISSN-L)
OpenAlex
W2116661471
Cited by
466
References
137
FWCI
13.05
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Practical Aspects of microRNA Target Prediction. https://app.cochat.ai/papers/10.2174/156652411794859250
The paper
M. Witkos, T., Koscianska, E., & J. Krzyzosiak, W. (2011). Practical Aspects of microRNA Target Prediction. Current Molecular Medicine. https://doi.org/10.2174/156652411794859250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.